• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分泌型 APP 外显段 sAPPα,而非 sAPPβ,可保护神经元免受 Aβ 寡聚体诱导的树突棘丢失和 tau 过度磷酸化。

The secreted APP ectodomain sAPPα, but not sAPPβ, protects neurons against Aβ oligomer-induced dendritic spine loss and increased tau phosphorylation.

机构信息

Institute for Regenerative Medicine, University of Zurich, Schlieren, Switzerland.

Neuroscience Center Zurich, University of Zurich, Zurich, Switzerland.

出版信息

Mol Brain. 2019 Mar 29;12(1):27. doi: 10.1186/s13041-019-0447-2.

DOI:10.1186/s13041-019-0447-2
PMID:30922360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6440141/
Abstract

AIM

The amyloid precursor protein (APP) is endoproteolytically processed to generate either the neurotoxic beta-amyloid peptide (Aβ) or the secreted ectodomain APP alpha (sAPPα). While neurotrophic properties of sAPPα were suggested in several studies, it is still unclear if and how sAPPα counteracts pathogenic effects of Aβ. Direct comparisons with sAPPβ, produced in the Aβ-generating pathway, are missing in order to determine the role of sAPPα's carbonyl-terminal end in its possible neuroprotective activity.

METHODS

Mouse neuronal primary cultures and hippocampal slices were treated with oligomeric Aβ. The effects on tau phosphorylation and dendritic spine densities were assessed by western blot and confocal imaging, respectively. Co-administration of either sAPPα or sAPPβ was used to determine activity on Aβ-induced toxicity.

RESULTS/DISCUSSION: We found that oligomeric Aβ strongly increased AT8 and AT180 phosphorylation of tau and caused a loss of dendritic spines. SAPPα completely abolished Aβ effects whereas sAPPβ had no such rescue activity. Interestingly, sAPPα or sAPPβ alone neither affected tau phosphorylation nor dendritic spine numbers. Together, our data suggest that sAPPα specifically protects neurons against Aβ-dependent toxicity supporting the strategy of activating α-secretase-dependent endoproteolytic APP processing to increase sAPPα shedding from the neuronal plasma membrane as a therapeutic intervention for the protection of dendritic spines and phospho-tau-dependent toxicity in Alzheimer's disease.

摘要

目的

淀粉样前体蛋白(APP)经内肽酶切割生成神经毒性β-淀粉样肽(Aβ)或分泌型 APP 外显子α(sAPPα)。尽管有几项研究表明 sAPPα 具有神经营养作用,但 sAPPα 是否以及如何抵消 Aβ 的致病作用仍不清楚。为了确定 sAPPα 的碳末端在其可能的神经保护活性中的作用,尚缺乏与 Aβ 生成途径中产生的 sAPPβ 的直接比较。

方法

用寡聚 Aβ 处理原代培养的小鼠神经元和海马切片。通过 Western blot 和共聚焦成像分别评估对 tau 磷酸化和树突棘密度的影响。共给予 sAPPα 或 sAPPβ 以确定其对 Aβ 诱导的毒性的作用。

结果/讨论:我们发现,寡聚 Aβ 可强烈增加 tau 的 AT8 和 AT180 磷酸化,并导致树突棘丢失。sAPPα 完全消除了 Aβ 的作用,而 sAPPβ 则没有这种挽救活性。有趣的是,sAPPα 或 sAPPβ 本身既不影响 tau 磷酸化,也不影响树突棘数量。总之,我们的数据表明 sAPPα 特异性保护神经元免受 Aβ 依赖性毒性,支持激活α-分泌酶依赖性 APP 内肽酶切割以增加 sAPPα 从神经元质膜脱落的策略,作为保护树突棘和阿尔茨海默病中磷酸化 tau 依赖性毒性的治疗干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1817/6440141/dadd29e88072/13041_2019_447_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1817/6440141/dadd29e88072/13041_2019_447_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1817/6440141/dadd29e88072/13041_2019_447_Fig1_HTML.jpg

相似文献

1
The secreted APP ectodomain sAPPα, but not sAPPβ, protects neurons against Aβ oligomer-induced dendritic spine loss and increased tau phosphorylation.分泌型 APP 外显段 sAPPα,而非 sAPPβ,可保护神经元免受 Aβ 寡聚体诱导的树突棘丢失和 tau 过度磷酸化。
Mol Brain. 2019 Mar 29;12(1):27. doi: 10.1186/s13041-019-0447-2.
2
Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis.转甲状腺素蛋白的中和作用逆转了分泌型淀粉样前体蛋白(APP)在APPSW小鼠中的神经保护作用,导致tau蛋白磷酸化和海马神经元丢失:对淀粉样蛋白假说的支持。
J Neurosci. 2004 Sep 1;24(35):7707-17. doi: 10.1523/JNEUROSCI.2211-04.2004.
3
CNS amyloid-β, soluble APP-α and -β kinetics during BACE inhibition.BACE抑制过程中中枢神经系统淀粉样β蛋白、可溶性APP-α和-β的动力学
J Neurosci. 2014 Jun 11;34(24):8336-46. doi: 10.1523/JNEUROSCI.0540-14.2014.
4
sAPPβ and sAPPα increase structural complexity and E/I input ratio in primary hippocampal neurons and alter Ca homeostasis and CREB1-signaling.sAPPβ 和 sAPPα 增加原代海马神经元的结构复杂性和 E/I 输入比,并改变钙稳态和 CREB1 信号转导。
Exp Neurol. 2018 Jun;304:1-13. doi: 10.1016/j.expneurol.2018.02.010. Epub 2018 Feb 18.
5
Amyloid precursor protein glycosylation is altered in the brain of patients with Alzheimer's disease.阿尔茨海默病患者大脑中的淀粉样前体蛋白糖基化发生改变。
Alzheimers Res Ther. 2020 Aug 12;12(1):96. doi: 10.1186/s13195-020-00664-9.
6
Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.淀粉样β肽序列第 22 位的家族性阿尔茨海默病突变在体外系统中不同程度地影响突触丢失、tau 磷酸化和神经元细胞死亡。
PLoS One. 2020 Sep 23;15(9):e0239584. doi: 10.1371/journal.pone.0239584. eCollection 2020.
7
Tau phosphorylation and tau mislocalization mediate soluble Aβ oligomer-induced AMPA glutamate receptor signaling deficits.tau蛋白磷酸化和tau蛋白错误定位介导可溶性Aβ寡聚体诱导的AMPA谷氨酸受体信号转导缺陷。
Eur J Neurosci. 2014 Apr;39(7):1214-24. doi: 10.1111/ejn.12507.
8
Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.阿尔茨海默病患者脑脊液中的可溶性淀粉样前体蛋白 α 和 β。
Brain Res. 2013 Jun 4;1513:117-26. doi: 10.1016/j.brainres.2013.03.019. Epub 2013 Mar 27.
9
Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex.阿尔茨海默病患者大脑中可溶性淀粉样前体蛋白 β(sAPPβ)减少。
J Neurosci Res. 2011 Jun;89(6):822-32. doi: 10.1002/jnr.22618. Epub 2011 Mar 23.
10
Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau.不同的信号通路介导由β-淀粉样蛋白、野生型tau蛋白和R406W tau蛋白诱导的树突棘改变和细胞死亡。
J Neurosci. 2009 Nov 18;29(46):14439-50. doi: 10.1523/JNEUROSCI.3590-09.2009.

引用本文的文献

1
The potential link between the development of Alzheimer's disease and osteoporosis.阿尔茨海默病的发展与骨质疏松症之间的潜在联系。
Biogerontology. 2025 Jan 20;26(1):43. doi: 10.1007/s10522-024-10181-z.
2
Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems.阿尔茨海默病治疗的最新观点:血脑屏障和基于抗氧化剂的药物传递系统的作用。
Molecules. 2024 Aug 27;29(17):4056. doi: 10.3390/molecules29174056.
3
CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response.

本文引用的文献

1
The Role of ADAM10 in Alzheimer's Disease.ADAM10在阿尔茨海默病中的作用。
J Alzheimers Dis. 2017;58(2):303-322. doi: 10.3233/JAD-170061.
2
Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.恢复可溶性淀粉样前体蛋白α的功能作为阿尔茨海默病的一种潜在治疗方法。
J Neurosci Res. 2017 Apr;95(4):973-991. doi: 10.1002/jnr.23823. Epub 2016 Aug 17.
3
Soluble amyloid precursor protein alpha inhibits tau phosphorylation through modulation of GSK3β signaling pathway.可溶性淀粉样前体蛋白α通过调节糖原合成酶激酶3β信号通路抑制tau蛋白磷酸化。
脑脊液生物标志物分析提示 ABCA7 突变携带者 APP 加工改变和炎症反应降低。
Alzheimers Res Ther. 2023 Nov 9;15(1):195. doi: 10.1186/s13195-023-01338-y.
4
SIRT2 as a potential new therapeutic target for Alzheimer's disease.SIRT2作为阿尔茨海默病潜在的新治疗靶点。
Neural Regen Res. 2024 Jan;19(1):124-131. doi: 10.4103/1673-5374.375315.
5
Amyloid precursor protein and its interacting proteins in neurodevelopment.淀粉样前体蛋白及其在神经发育中的相互作用蛋白。
Biochem Soc Trans. 2023 Aug 31;51(4):1647-1659. doi: 10.1042/BST20221527.
6
Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease.改变平衡:可溶性ADAM10作为阿尔茨海默病的潜在治疗方法。
Front Aging Neurosci. 2023 May 17;15:1171123. doi: 10.3389/fnagi.2023.1171123. eCollection 2023.
7
The US9-Derived Protein gPTB9TM Modulates APP Processing Without Targeting Secretase Activities.US9 衍生蛋白 gPTB9TM 在不靶向靶向酶活性的情况下调节 APP 加工。
Mol Neurobiol. 2023 Apr;60(4):1811-1825. doi: 10.1007/s12035-022-03153-2. Epub 2022 Dec 28.
8
Amyloid Beta in Aging and Alzheimer's Disease.β淀粉样蛋白与衰老和阿尔茨海默病。
Int J Mol Sci. 2022 Oct 26;23(21):12924. doi: 10.3390/ijms232112924.
9
The amyloid precursor protein: a converging point in Alzheimer's disease.淀粉样前体蛋白:阿尔茨海默病的交汇点。
Mol Neurobiol. 2022 Jul;59(7):4501-4516. doi: 10.1007/s12035-022-02863-x. Epub 2022 May 17.
10
Intercellular signaling by ectodomain shedding at the synapse.突触处通过胞外域脱落进行细胞间信号传递。
Trends Neurosci. 2022 Jun;45(6):483-498. doi: 10.1016/j.tins.2022.03.004. Epub 2022 Apr 13.
J Neurochem. 2015 Nov;135(3):630-7. doi: 10.1111/jnc.13351. Epub 2015 Sep 24.
4
Calcium flux-independent NMDA receptor activity is required for Aβ oligomer-induced synaptic loss.β淀粉样蛋白寡聚体诱导的突触丧失需要不依赖钙流的N-甲基-D-天冬氨酸受体活性。
Cell Death Dis. 2015 Jun 18;6(6):e1791. doi: 10.1038/cddis.2015.160.
5
NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss.NMDA 受体亚基组成决定β-淀粉样蛋白诱导的神经退行性变和突触丢失。
Cell Death Dis. 2013 Apr 25;4(4):e608. doi: 10.1038/cddis.2013.129.
6
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.多发性硬化症中β-淀粉样蛋白代谢的脑脊液生物标志物。
Mult Scler. 2013 Apr;19(5):543-52. doi: 10.1177/1352458512460603. Epub 2012 Oct 15.
7
Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.tau 异常过度磷酸化:部位、调节及神经原纤维变性的分子机制。
J Alzheimers Dis. 2013;33 Suppl 1:S123-39. doi: 10.3233/JAD-2012-129031.
8
Trafficking and proteolytic processing of APP.APP 的转运和蛋白水解加工。
Cold Spring Harb Perspect Med. 2012 May;2(5):a006270. doi: 10.1101/cshperspect.a006270.
9
Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau.不同的信号通路介导由β-淀粉样蛋白、野生型tau蛋白和R406W tau蛋白诱导的树突棘改变和细胞死亡。
J Neurosci. 2009 Nov 18;29(46):14439-50. doi: 10.1523/JNEUROSCI.3590-09.2009.
10
Pathways by which Abeta facilitates tau pathology.β-淀粉样蛋白促进tau蛋白病变的途径。
Curr Alzheimer Res. 2006 Dec;3(5):437-48. doi: 10.2174/156720506779025242.